Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Buzz on the Bullboards: The Cannabis Deal of a Lifetime?

(Image via Aphria Inc.) The fate of one of the biggest mergers in cannabis’ young history as a legal market will be decided tomorrow, when shareholders of Leamington ON-based licensed producer Aphria Inc. ( TSX: APHA , Forum ) vote on whet...
Stockhouse Editorial | April 28, 2021 |

Bridging the Gap Between E-Commerce, Plant-Based and Home Delivery Industries

(Click to play video.) The global meal kit delivery system is becoming increasingly popular and by 2027 it is expected to achieve $19.92 billion in value, expanding at a compound annual growth rate (CAGR) of 12.8%. Even more immense is the growth forecast for the g...
Featured Submission | February 22, 2021 |

Feb 7th 2020, Crypto Chartbook – The trend is your friend

The trend is your friend That might be an overused term but it is so very true! After “compound interest” (Albert Einstein: “Compound interest is the 8th wonder of the world”), a directional market is the strongest free e...
Korbinian Koller | February 10, 2020 |

BioNTech, Gilead, Memphasys - modern science and COVID and IVF

People around the world are worried about the extent of the consequences associated with the spread of the corona virus COVID-19, and politicians and the economy are called upon to deal with the situation appropriately so that the loss of life and financial damage to the citiz...
Mario Hose | March 19, 2020 |

Valeo Pharma In-Play, New HesperCo™ Immune System Support Scientifically Demonstrated

Shares of Valeo Pharma Inc. (CSE: VPH) (Frankfurt: VP2) poised for substantial upside revaluation to reflect the major ‘company –maker’ potential in HesperCo™ as the market figures out it is set to be the subject of Covid-19 clinical trial. Valeo will benefit...
Fredrick William | September 2, 2020 |

Biopharma to Test Immunity Activator in Advanced Solid Cancers

The company's plans for and approach to one of its most advanced drug candidates are discussed in an H.C. Wainwright & Co. report. In a Dec. 12 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that BioXcel Therapeutics Inc. (BTAI:NASDAQ) plans to ...
Streetwise Reports | December 19, 2019 |

Gold Projected to Beat the Market in 2020

Gold will outperform the S&P 500 Index in 2020. That’s one of several projections made by CLSA in its just-released “Global Surprises 2020” report. The Hong Kong investment firm has an impressive track record when it comes to maki...
Frank Holmes | February 10, 2020 |

BioNTech, CureVac, Valeo Pharma - Growth after capital injection

Anyone working in the medical sector knows that the development of therapies and products usually costs a lot of time and especially a lot of money. In the race against the spread of the current Corona pandemic, there are major changes in the industry, because whoever comes to...
Mario Hose | September 11, 2020 |

Biopharma Co. Makes Major Headway Toward Clinical Trials for Treatment of Stroke

(CLICK IMAGE TO PLAY VIDEO) Finding an effective method of preventing the possibility of stroke is something that medical science has grappled with for decades. Now, a Vancouver-based clinical stage biopharmaceutical development company looks to be making significa...
Dave Jackson | June 16, 2021 |

Buzz on the Bullboards: One Step Closer to a Canadian-Made COVID Vaccine?

(Image via Theralase Technologies Inc.) Clinical-stage pharmaceutical company Theralase Technologies Inc. ( TSX-V: TLT , Forum ) has demonstrated proof-of-concept for its Canadian-made COVID-19 vaccine. In collaboration with the University of Manitoba (UM), t...
Stockhouse Editorial | February 9, 2022 |
1 2 3 4 5 6 7 8